Collective Intelligence

The first interactive platform that brings together innovation players around common interest.

Innovation in Infectious Diseases: a Biocluster set-up in France

As part of the France 2030 Health innovation plan, the French Government announced the creation of 5 global Bioclusters by providing them with 400 million euros. Among those, the French Biocluster for Innovation in Infectiology (BCF2I) was selected.

Our comment :

Coordinated by Lyonbiopôle and in collaboration with the main national organizations involved in infectiology such as Institute Pasteur, this European Hub aims to accelerate progress in the field of emerging and infectious diseases hence strengthening our global pandemic preparedness.
Olivia Uguen, One health and ESG strategies expert
ClosePlease login
ClosePlease login

Innovation in Infectious Diseases: a Biocluster set-up in France

As part of the France 2030 Health innovation plan, the French Government announced the creation of 5 global Bioclusters by providing them with 400 million euros. Among those, the French Biocluster for Innovation in Infectiology (BCF2I) was selected.

BLUMORPHO comment :

Coordinated by Lyonbiopôle and in collaboration with the main national organizations involved in infectiology such as Institute Pasteur, this European Hub aims to accelerate progress in the field of emerging and infectious diseases hence strengthening our global pandemic preparedness.
Olivia Uguen, One health and ESG strategies expert
ClosePlease login
ClosePlease login

Innovation in Infectious Diseases: a Biocluster set-up in France

As part of the France 2030 Health innovation plan, the French Government announced the creation of 5 global Bioclusters by providing them with 400 million euros. Among those, the French Biocluster for Innovation in Infectiology (BCF2I) was selected.

BLUMORPHO comment :

Coordinated by Lyonbiopôle and in collaboration with the main national organizations involved in infectiology such as Institute Pasteur, this European Hub aims to accelerate progress in the field of emerging and infectious diseases hence strengthening our global pandemic preparedness.
Olivia Uguen, One health and ESG strategies expert
ClosePlease login
ClosePlease login
ClosePlease login
ClosePlease login
ClosePlease login
ClosePlease login

Our previous articles